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Abstract
One motivation of systems biology research is to understand gene functions and interactions from functional genomics
data such as that derived from microarrays. Up-to-date structural and functional annotations of genes are an essential
foundation of systems biology modeling. We propose that the first essential step in any systems biology modeling of
functional genomics data, especially for species with recently sequenced genomes, is gene structural and functional re-
annotation. To demonstrate the impact of such re-annotation, we structurally and functionally re-annotated a microarray
developed, and previously used, as a tool for disease research. We quantified the impact of this re-annotation on the array
based on the total numbers of structural- and functional-annotations, the Gene Annotation Quality (GAQ) score, and
canonical pathway coverage. We next quantified the impact of re-annotation on systems biology modeling using a
previously published experiment that used this microarray. We show that re-annotation improves the quantity and quality
of structural- and functional-annotations, allows a more comprehensive Gene Ontology based modeling, and improves
pathway coverage for both the whole array and a differentially expressed mRNA subset. Our results also demonstrate that
re-annotation can result in a different knowledge outcome derived from previous published research findings. We propose
that, because of this, re-annotation should be considered to be an essential first step for deriving value from functional
genomics data.
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Introduction
Integrating and modeling ‘omics’ datasets in systems biology
facilitates biological understanding at a molecular systems level.
Biological systems are studied from global gene, transcript,
protein, protein interaction and metabolite levels. Microarray
technology advanced functional genomics by facilitating high-
throughput acquisition of large functional genomics datasets
[1,2,3]. We can derive a system-level understanding from
functional genomics data through modeling based, for example,
on Gene Ontology (GO) [4] as well as canonical pathway and
network analyses.
Up-to-date gene product structural- and functional- annotations
(i.e. identifying the genes represented on microarrays and linking
these to functional information, respectively) are an essential
foundation of systems biology modeling. The primary repository
for structural annotations of most commercial and custom-made
microarrays, and their related studies, is the National Center for
Biotechnology Information (NCBI) Gene Expression Omnibus
[5]. Structural annotations are assigned during microarray
development and initial publication. However, these structural
annotations are not always regularly updated after publication.
With the acquisition of new genomics data and development of
annotation tools, the structural- and functional-annotation data-
bases are updated on a regular basis [6,7,8].
For species for which genomic sequences are newly available,
the rapidity of updates of annotation data and the increase in high-
throughput experimental platforms, such as microarrays, is
astounding. The challenge of appropriately managing and,
especially, interpreting experiment-based datasets will be especially
difficult for those species with small research communities, such as
ecologically important or agricultural animal species. The number
of animal species completely sequenced and published before 2003
was 6 (Drosophila melanogaster, Anopheles gambiae, Mus musculus, Homo
sapiens, Caenorhabditis elegans, and Caenorhabditis briggsae). From 2003
to present, 103 animal genomes are completely sequenced and
published, and this trajectory of data generation is expected to
increase. Chicken is one animal that exemplifies the rapidly
evolving structural and functional annotations. The chicken
UniGene clustering database, the major repository for structural
annotation of ESTs, was first released in 2003, and was developed
up to build 40 used here. This is an average of one update every
two months. The GO consortium is the primary repository for
functional annotations. GO functional annotations are continually
updated and on average there is a new chicken GOA database
released monthly; from June 5th 2004 there have been 46 releases.
PLoS ONE | www.plosone.org 1 May 2010 | Volume 5 | Issue 5 | e10642
Disregarding this new and/or corrected information will limit the
power of using functional genomics methods and hinder compre-
hensive system-level modeling. It is logical to first update the
structural and functional annotations of functional genomics datasets
before they are used as part of a systems biology modeling paradigm.
Although genome-wide gene structural re-annotation has proven
valuable [9,10,11,12,13,14,15,16,17,18], a corresponding genome-
wide gene functional re-annotation is not frequently considered.
Here we use the FHCRC Chicken 13K cDNA v.2.0 microarray
(GPL 1836) [19] as an example of both the power gain and
necessity of updating genome annotations for accurate modeling.
This array has been used to characterize global gene expression for
cancer [20,21,22], host-pathogen interactions [23,24], and
developmental biology [25]. The FHCRC microarray was
developed and structurally-annotated in 2004. After publication
in February 2005, the structural annotations were updated only
once in January 2006 (GEO accession GPL2863). However, since
the release of the chicken genome in 2004 [26], new and/or
corrected structural- and functional- annotations have been
assigned [27,28,29,30,31,32]. We re-annotated the FHCRC
chicken 13K cDNA v2.0 microarray and reanalysed a previously
published differentially expressed mRNA experimental dataset
generated with this microarray [24]. We compared the quality of
the new annotations with that of the prior annotations as well as
the results of modeling. We show that re-annotation not only
provides more structural- and functional-annotations but also
improves the power of functional genomics modeling, and that re-
analysis after re-annotation can provide different interpretations
compared with data whose annotation is less optimal.
Results
All structural mappings, GO term assignments and pathway
analysis are available on the AgBase website at http://agbase.
msstate.edu/tools/reannotation/.
Structural re-annotation
Table 1 shows the results for the structural re-annotation of the
whole FHCRC chicken 13K cDNA v2.0 (GPL 1836) microarray
and the differentially expressed mRNA data from Zhou et al. [24].
For the whole microarray, 15,609 ESTs were listed originally in
the microarray data table. Because the ESTs are generated from
chicken cells and tissues, we aimed to retrieve only chicken
structural annotations. We were able to increase the chicken-
specific annotations (i.e. annotate an EST to a chicken gene) by
9.8-fold. Even though structural annotations could not be assigned
for all ESTs in the re-annotated dataset, the number of ESTs with
no structural annotations was reduced to 15% of the original ESTs
with no structural annotation. The total number of unique chicken
genes assigned to the whole array was improved by 10.5-fold.
For the differentially expressed mRNAs, 57 were originally
identified to play a significant role in the host-pathogen response
within a Salmonella enterica Serovar enteritidis-challenged chicken model
[24]. We retrieved 54 unique identifiers from these ESTs and re-
annotated them with ArrayIDer. We mapped 49 ESTs to correspond-
ing chicken genes, which is an increase of 3.1-fold compared to the
original data. Only 5 of the 54 ESTs did not have structural
annotations, compared to 13 in the original dataset. The total unique
chicken gene annotations were increased by almost 2.7-fold.
Functional re-annotation
Table 2 shows the results for the functional re-annotation of the
whole FHCRC 13K chicken cDNA microarray and the
differentially expressed mRNA data from Zhou et al. [24]. We
retrieved all possible proteins for the total number of genes
annotated on the whole microarray. We used the GOA chicken
database build 17 as baseline for functional annotations available
at the time of the study reported by Zhou et al. [24]. We used the
GOA chicken database build 46 as a functional annotation
resource for the re-annotation. Originally, 785 unique proteins
were identified of which 615 proteins had functional annotations
assigned in the GOA chicken database build 17. We retrieved
15.1-fold more chicken proteins for the whole microarray after re-
annotation and the total number of proteins that had functional
annotations assigned was increased by more than 6.2-fold.
The re-annotation not only increased the number of structural
annotations, but also greatly increased the number of functional
annotations. The total number of GO terms represented by the
retrieved proteins increased more than 7.0-fold and the total
number of unique GO terms by more than 2.5-fold. To quantify
the quality of the functional annotations assigned to our re-
annotated data set we calculated the GAQ score. The GAQ score
consists of the total number of proteins, the GO term depth in the
GO tree and the assigned evidence code for the GO annotation
[33]. The total GAQ score for the retrieved GO annotations
improved more than 7.0-fold (P,0.235).
Table 1. Structural re-annotation results.
Whole microarray data Differentially expressed mRNA data
Structural annotation Original Re-annotated Fold D Original Re-annotated Fold D
Total EST 15,609 15,227 0.98 57 54 0.95
EST to Chicken gene 1,457 14,206 9.75 16 49 3.06
EST to Human gene 3,951 0 n/a 13 0 n/a
EST to Mouse gene 1,487 0 n/a 5 0 n/a
EST to Rat gene 450 0 n/a 3 0 n/a
EST to genes other species 1,409 0 n/a 7 0 n/a
EST with no gene annotation 6,855 1,032 0.15 13 5 0.38
Total unique chicken gene annotations 1,136 11,868 10.45 16 43 2.69
The results of structural annotation are compared between the original annotation data and the re-annotation dataset for both the whole microarray as for the
differentially expressed mRNA dataset. Re-annotation increased EST to chicken gene mapping and total unique chicken genes, in both the whole microarray as for the
differentially expressed mRNA dataset, while reducing need for structural annotations based on orthology.
doi:10.1371/journal.pone.0010642.t001
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Although we greatly increased the number of GO annotations,
the increase of total GAQ score from 43,245 to 305,996 is not
statistically significantly different because of the large number of
GO annotations assigned with the lower scoring evidence codes
‘ND’ (No Data) and ‘IEA’ (Inferred by Electronic Annotation).
However, the mean GAQ score (i.e. total GAQ score/total
number of unique proteins) was statistically significantly increased
by 13% compared to the original (P,0.002) i.e. the GO
annotation quality per protein improved after re-annotation.
The GO depth score improved more than 6.5-fold, demonstrating
an increased level of biological detail for the re-annotated dataset.
The overall GO annotation confidence score, (a measure of the
difference in quality of different types of annotations) improved
more than 7.1-fold. In addition, to assess the confidence
improvement without the down-weighting caused by IEA evidence
code scores in the total GAQ score, we calculated the GO
annotation confidence score excluding IEA evidence code scores.
The GO annotation confidence score based on annotations that
themselves are based on data derived from experimental assays
improved more than 10.7-fold, demonstrating that we can be
more confident about the assigned annotations in the re-annotated
whole microarray dataset.
The impact of re-annotation is especially well demonstrated for
the 615 proteins that were originally annotated to chicken
(numbers in parentheses in Table 2). Even though these proteins
were the best-annotated previously, we improved the total number
of GO terms almost 2.5-fold and the number of unique GO terms
by almost 60%. The total GAQ and mean GAQ scores both
increased by almost 2.5-fold (P,0.044 and P,2.7e-78, respec-
tively). This results in greater depth and confidence in the
knowledge represented by these 615 proteins as demonstrated by
the almost 2.5-fold increase of in total GO depth and total GO
annotation confidence score. The GO annotation confidence score
calculated excluding IEA evidence code annotations improved
over 2.6-fold.
For the differentially expressed mRNA data, we retrieved
almost 3.6-fold more proteins, with 9.4-fold more total GO terms,
and over 6.1-fold more unique GO terms. Similar to the whole
array, we calculated the total and mean GAQ scores for the
differentially expressed mRNA dataset and this increased more
than 11.0- and 2.6-fold respectively (P,0.023 and P,5.4e-6,
respectively). The total GO depth score and total GO annotation
confidence score both increased by more than 10.8- and 9.6-fold
respectively.
GOSlim modeling
We generated GOSlim models for cellular component [CC],
molecular function [MF] and biological process [BP] Gene
Ontology for the microarray and differentially expressed mRNA
dataset to visualize the major functional groups represented. We
used the ‘‘GOA and whole proteome’’ GOSlim set [34]. Figure 1
shows the net difference between the re-annotated and original
GOSlim distribution for the whole microarray. After re-annota-
tion, all CC, MF and BP GOSlim groups contain more GO
annotations. The GOSlim groups ‘‘cellular_component’’, ‘‘molecular_
function’’ and ‘‘biological_process’’ also include GO annotations
made to the GO term ‘‘component unknown’’. Figure 2 shows
the difference between the re-annotated and original GOSlim
distribution for the differentially expressed mRNA dataset. After
re-annotation, all CC GOSlim groups contain more GO
annotations; 15 out of 16 MF GOSlim groups contain more
GO annotations; and all BP GOSlim groups contained more GO
annotations. The negative value for the GOSlim group
‘‘transporter activity’’ is due to the re-distribution of the GO
annotation to the more detailed GOSlim group ‘‘proteins
transporter activity’’. Such re-distribution occurs when new
GO annotation becomes available or when older GO annota-
tions are updated. For example, chicken CD3 epsilon (Uni-
ProtKB accession Q98910) was integrated to the UniProtKB/
Swiss-Prot database on the November 1, 1997, yet received its
first GO annotation on the November 4, 2008 and the second
GO annotation on November 25, 2008. Regardless, the large
differences before and after re-annotation show that re-
annotation shifted the balance of genes represented on the array
from developmental to metabolic processes.
Pathway and molecular network analysis
We used Ingenuity Pathway Analysis (IPA) to retrieve and
compare the significant genetic pathways and networks able to be
modeled by both the original and re-annotated whole microarray
Table 2. Functional re-annotation results.
Whole microarray data Differentially expressed mRNA data
Functional annotation Original Re-annotated Fold D Original Re-annotated Fold D
Total unique chicken protein annotations 785 11,868 15.10 12 43 3.58
Total proteins GO annotated 615 3,845 6.25 9 38 4.22
Total GO terms 3,929 27,815 (9,595) 7.08 (2.44) 39 365 (190) 9.36 (4.87)
Unique GO terms 1,050 2,652 (1,662) 2.53 (1.58) 26 160 (92) 6.15 (3.54)
Total GAQ score 43,245 305,996 (107,006) 7.08 (2.47) 375 4,158 (2663) 11.08 (6.04)
Mean GAQ score 70 80 (174) 1.13 (2.49) 42 109 (296) 2.63 (7.05)
GO depth score 21,142 143,206 (51,391) 6.77 (2.43) 177 1,921 (934) 10.85 (5.28)
gGO annotation confidence score including IEA 8,037 57,696 (20,040) 7.18 (2.49) 81 781 (527) 9.64 (6.51)
gGO annotation confidence score excluding IEA 1,325 14,258 (3,460) 10.76 (2.61) 5 143 (283) 28.60 (56.6)
The results of functional annotation are compared between the original annotation data and the re-annotation dataset for both the whole microarray as for the
differentially expressed mRNA dataset. In addition, re-annotation increased the number of GO terms, the total GAQ score, the detail and the confidence in the GO
annotations assigned. The numbers in parentheses represent the re-annotation results of only the original 615 chicken proteins of the whole array data. This score
represents the standard baseline of the impact of re-annotation improvement. For the differentially expressed mRNA data, the numbers in parentheses represent the re-
annotation results of the original 9 differentially expressed mRNAs.
doi:10.1371/journal.pone.0010642.t002
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and differentially-expressed mRNA datasets. We identified 133
pathways common to both the original and re-annotated whole
microarray dataset. Although these pathways are all shared, the
pathway coverage was increased 6.9-fold, with a coverage variance
of only 49% of the original variance. We identified 35 pathways
unique to the original dataset and 37 unique to the re-annotated
data. However, unique original dataset pathways were identified
with 91 genes and mean coverage of 4.2%. In contrast, unique re-
annotated dataset pathways were identified with 608 genes and
mean coverage of 25.4%. Table 3 and 4 lists the top 10 significant
pathways identified in the original (Table 3) and re-annotated
(Table 4) whole array datasets. Only two out of ten pathways are
shared (indicated in bold). The mean pathway coverage ratio for
the pathways (i.e. number of genes in datasets/total number of
genes in pathway) represented for the original annotations is 0.090
but for the re-annotated data is 0.445 (i.e. 5-fold increase).
We identified 34 pathways shared between the original and re-
annotated differentially expressed mRNA datasets. Similar to the
whole array, the pathway coverage in the re-annotated dataset was
increased 6.3-fold, with a coverage variance of 61% of the original
Figure 1. Whole microarray GOSlim modelling. The difference in number of GO annotations in the GOSlim groups for the GO ontologies
‘cellular component’, ‘molecular function’ and ‘biological process’ between the original and re-annotated whole microarray gene dataset. The whole
microarray GOSlim modeling shows that re-annotation increases the number of GO annotations in each GOSlim group for each ontology.
doi:10.1371/journal.pone.0010642.g001
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variance. Fourteen pathways were unique to the re-annotated
differentially expressed mRNA dataset. Table 5 and 6 lists the top
10 of the significant shared pathways identified in the original
(Table 5) and re-annotated (Table 6) differentially expressed
mRNA datasets. The mean pathway coverage ratio for the
pathways (i.e. number of genes in datasets/total number of genes
in pathway) represented for the original annotations is 0.018 but
for the re-annotated data is 0.030 (i.e. 1.6-fold increased). Re-
annotation improves canonical pathway coverage and shifts the
pathway identification significance. Three out of the top ten
pathways are shared (Table 5 and 6, bold) between the original
and re-annotated datasets.
Intuitively the re-annotated set should contain pathways not
detected in the original analysis; however, almost as many
pathways were unique to the original analysis by Zhou et. al.
[24] as were unique to analysis of the re-annotated data set. This is
a property of the statistical methods used by IPA. In short, IPA
identifies pathways using a Fisher’s exact test to calculate the
Figure 2. Differentially Expressed mRNA GOSlim modelling. The difference in number of GO annotations in the GOSlim groups for the GO
ontologies ‘cellular component’, ‘molecular function’ and ‘biological process’ between the original and re-annotated differentially expressed mRNA
dataset. The differentially expressed mRNA GOSlim modeling shows that re-annotation increases the number of GO annotations for most GOSlim
group. The negative value for the GOSlim group ‘transporter activity’ in the ‘molecular function’ ontology are caused by updated GO annotations to
the more detailed ‘protein transporter activity’ GOSlim group.
doi:10.1371/journal.pone.0010642.g002
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probability that the association between the genes in the dataset
and the canonical pathway is explained by chance alone relative to
all other pathways in the database chosen for interrogation
(IngenuityH Systems, www.ingenuity.com), but not relative to the
proportional coverage of the pathway. The proportion of proteins
in a given pathway is given by the ‘‘ratio coverage’’ i.e. the number
of genes from the data set that map to the pathway divided by the
total number of genes that map to the canonical pathway. Re-
annotation resulted in 4.5- and 1.7-fold improvements in mean
pathway ratio coverage in the entire and differentially-expressed
datasets, respectively (Tables 3 through 6) and thus greater
confidence in the pathways identified after re-annotation.
Discussion
Comprehensive and accurate structural and functional annota-
tion is fundamental for modeling functional genomics data to
derive biological knowledge. Commercial and custom-spotted
microarrays are often annotated before their publication and are
sometimes not updated to provide the most recent and corrected
structural and functional annotations. We demonstrate that re-
annotation of a microarray provided not only more information
but also better statistical confidence in the functional annotations.
An important distinction is that between genome re-annotation
and data set re-annotation. Most references use the term ‘‘re-
annotation’’ in the context of genome re-annotation (i.e. updating
annotations in a genomic database). The assumption being that
the genome annotation is current. In contrast, here we have re-
annotated a functional genomics data set itself. However, we are
aware that a potential issue confounding functional genomics data
re-annotation is annotation error in the genomic databases
[35,36,37,38].
Although structural and functional re-annotation of functional
genomic datasets should be intuitive we have not seen that doing
such a re-annotation is commonly reported in the material and
methods section of the published literature. Here we aimed to
provide a quantitative example of the importance of such re-
annotation (especially when working in a less widely-used model
species). Previously this same dataset was structurally re-
annotated when we designed an automated method (ArrayIDer)
for microarray [32] structural re-annotation. But because of
changes in annotation over the less than 12 months since this
annotation, we used ArrayIDer to further update these structural
annotations. In the original publication, only 1131 ESTs were
structurally annotated based on chicken genes, while the
remainder of the microarray was structurally annotated using
orthologs from 249 different species [19]. We not only retrieved
more structural annotations, but also improved the specificity of
these structural annotations by assigning structural annotations
from chicken only. In addition to updating the structural
annotations, we also did manual curation of poorly annotated
ESTs to improve the structural annotation breadth. The ESTs
without any current structural annotations are candidates for
orthology-based structural annotation. We did not attempt to
retrieve any orthologs for the annotated ESTs as this adds the
variable of ortholog assignment [39,40,41], which was beyond the
scope of this work.
While it may be interesting to compare our GAQ score-based
quantitative analysis with another metric for measuring for
functional annotation quality, no similar method exists. The
Genome Annotation Score (GAS) [42], the Gene Characterization
Index (GCI) [43] and the GeneCard Inferred Functionality Score
(GIFtS) [44] are additional algorithms that assess gene annotation
quality. The GAS algorithm weighs the annotation evidence code
in its GO annotation scoring, but it only distinguishes automat-
ically- from manually-assigned annotations. In comparison, the
GAQ weighs each annotation evidence code separately and the
automatically assigned evidence code is lowest scoring. In
addition, GAS only calculates an average, whole genome quality
score, while GAQ calculates the quality score for each gene, so
providing higher resolution for the annotation quality scoring.








1 Apoptosis Signaling 1.17E-01 11
2 Axonal Guidance Signaling 6.42E-02 26
3 Integrin Signaling 8.37E-02 17
4 Amyotrophic Lateral Sclerosis Signaling 9.09E-02 10
5 Actin Cytoskeleton Signaling 7.14E-02 17
6 CDK5 Signaling 9.68E-02 9
7 Caveolar-mediated Endocytosis 9.76E-02 8
8 Neurotrophin/TRK Signaling 1.15E-01 9
9 VEGF Signaling 9.28E-02 9
10 Clathrin-mediated Endocytosis 7.19E-02 12
MEAN 9.01E-02
Top 10 of significant pathways identified by Ingenuity Pathway Analysis for the
original whole microarray dataset. Pathways in bold were found in the top 10
series of both the original and re-annotated datasets. Ratio Coverage = the
number of genes from the data set that map to the pathway divided by the
total number of genes that map to the canonical pathway is displayed
(IngenuityH Systems).
doi:10.1371/journal.pone.0010642.t003








1 CD28 Signaling in T Helper Cells 4.52E-01 56
2 Integrin Signaling 4.68E-01 95
3 NF-kB Signaling 4.29E-01 63
4 Insulin Receptor Signaling 4.49E-01 62
5 Apoptosis Signaling 4.79E-01 45
6 IL-9 Signaling 4.59E-01 17
7 Role of NFAT in Regulation
of the Immune Response
3.72E-01 70
8 Angiopoietin Signaling 4.17E-01 30
9 Ceramide Signaling 4.76E-01 40
10 Virus Entry via Endocytic Pathways 4.48E-01 43
MEAN 4.45E-01
Top 10 of significant pathways identified by Ingenuity Pathway Analysis for the
re-annotated whole microarray dataset. Pathways in bold were found in the top
10 series of both the original and re-annotated datasets. Ratio Coverage = the
number of genes from the data set that map to the pathway divided by the
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Similarly, the GCI algorithm does not take the annotation
evidence code into consideration.
The GIFtS algorithm calculates a gene’s annotation quality
score using a binary vector system (either ‘0’ or ‘1’) representing
either the presence or absence of data. In effect, if one gene has 3
annotations and another gene 10 annotations, both will be scored
equally. In contrast, the GAQ scoring algorithm assigns scores for
each annotation for a particular gene individually and so better
annotated genes score higher.
In addition, GAQ uses the ‘depth’ of a GO term in the GO
acyclic graph as a quantitative measure for the level of annotation
detail, the GAS, GCI and GIFtS algorithms do not take the GO
annotation’s level of detail in consideration. Finally, unlike the
GAQ algorithm, GAS does not allow direct input of large
numbers of gene product accession numbers and, although GIFtS
and GCI can do so, both algorithms are limited only to human
genes and requires ortholog-searching to be used for any other
species.
We used the GAQ score to assess the improvement in functional
annotations after re-annotation of the FHCRC Chicken 13K
cDNA v2.0 microarray and a differentially expressed mRNA set
from a previous study using this microarray. At the time of writing,
97.1% of all chicken GO annotations in the GOA database are
‘‘Inferred by Electronic Annotation’’ (IEA). Because we have more
functional annotations (‘breadth’) in the re-annotated whole
FHCRC microarray dataset, the proportion of IEA, together
with the higher number of proteins in the re-annotated dataset,
cause the 7.08-fold increase of the total GAQ score not to be
significant. However, even though the mean GAQ score increased
only by 13%, this increase of the mean GAQ score is a marked
improvement compared to the original annotation.
In addition, the GAQ score down-weights annotations inferred
electronically compared to those inferred by experimental assays.
Were we to exclude the IEA annotations then the power to model
the data would reduce because fewer proteins would have
annotations (i.e. annotation ‘‘breadth’’ decreases); but the mean
Table 5. Top 10 significant pathways original differentially expressed mRNA dataset.
Rank Pathway Original Ratio coverage Genes from dataset
1 Hepatic Fibrosis/Hepatic Stellate Cell Activation 2.22E-02 CCL5, FN1, IL1B
2 Acute Phase Response Signaling 1.12E-02 FN1, IL1B
3 Glucocorticoid Receptor Signaling 1.08E-02 CD3E, CCL5, IL1B
4 Role of Cytokines in Mediating Communication between Immune Cells 1.79E-02 IL1B
5 Cytotoxic T Lymphocyte-mediated Apoptosis of Target Cells 3.7E-02 CD3E
6 Docosahexaenoic Acid (DHA) Signaling 2.22E-02 IL1B
7 TREM1 Signaling 1.45E-02 IL1B
8 IL-10 Signaling 1.41E-02 IL1B
9 Calcium-induced T Lymphocyte Apoptosis 1.61E-02 CD3E
10 LXR/RXR Activation 1.18E-02 IL1B
MEAN 1.78E-02
Top 10 of significant pathways identified by Ingenuity Pathway Analysis for the original differentially expressed mRNA dataset. Pathways in bold were found in the top
10 series of both the original and re-annotated datasets. Genes in bold and italics were only identified in the re-annotated dataset. Ratio Coverage = the number of
genes from the data set that map to the pathway divided by the total number of genes that map to the canonical pathway is displayed (IngenuityH Systems).
doi:10.1371/journal.pone.0010642.t005
Table 6. Top 10 significant pathways re-annotated differentially expressed mRNA dataset.
Rank Pathway Original Ratio coverage Genes from dataset
1 Cytotoxic T Lymphocyte-mediated Apoptosis of Target Cells 7.41E-02 CD3E, FAS
2 Hepatic Fibrosis/Hepatic Stellate Cell Activation 3.7E-02 CCL5, FN1, IL1B, FAS, LY96
3 CCR5 Signaling in Macrophages 3.45E-02 CD3E, CCL5, FAS
4 Death Receptor Signaling 3.08E-02 BIRC2
5 Induction of Apoptosis by HIV1 3.03E-02 BIRC2, FAS
6 Glucocorticoid Receptor Signaling 1.44E-02 CD3E, CCL5, IL1B, ANXA1
7 p38 MAPK Signaling 2.11E-02 IL1B, FAS
8 CTLA4 Signaling in Cytotoxic T Lymphocytes 2.25E-02 CD3E, AP1G1
9 Apoptosis Signaling 2.13E-02 BIRC2, FAS
10 Role of Cytokines in Mediating Communication between Immune Cells 1.79E-02 IL1B
MEAN 3.04E-02
Top 10 of significant pathways identified by Ingenuity Pathway Analysis for the re-annotated differentially expressed mRNA dataset. Pathways in bold were found in the
top 10 series of both the original and re-annotated datasets. Genes in bold and italics were only identified in the re-annotated dataset. Ratio Coverage = the number of
genes from the data set that map to the pathway divided by the total number of genes that map to the canonical pathway is displayed (IngenuityH Systems).
doi:10.1371/journal.pone.0010642.t006
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GAQ for each gene would increase because the lower scoring
proteins would be excluded. Regardless, IEA is a valid method to
annotate to the GO and, so long as the evidence code is kept in
mind during modeling, then we consider IEA annotations valuable
additions—especially in model organisms other than mouse. For
this reason we included the GO annotation confidence score (a
measure of the difference in quality of different types of
annotations) calculated without the lowest scoring, most common
IEA annotations, and doing so demonstrates that re-annotation
even without IEA is an improvement.
We calculated the GO annotation confidence score excluding
IEA evidence code scores to measure the improved annotation
without the down-weighting caused by IEA evidence code scores
(Table 2).
For the original whole microarray annotation, the ratio of the
GO annotation confidence score including and excluding IEA,
before re-annotation is 6.1 (8037 vs. 1325) and after re-annotation
5.8 (20040 vs. 3460). For the differentially expressed mRNA
annotation, the ratio of the GO annotation confidence score
including and excluding IEA, before re-annotation is 9.1 (81 vs. 5)
and after re-annotation 1.9 (527 vs. 283).
Although the general trend is similar before and after re-
annotation of the original whole microarray dataset, there is an
exception for the differentially expressed mRNA dataset. We
believe that this difference is due to the structural re-annotation of
mRNA clones to corrected, up-to-date structural annotations with
less functional annotations assigned.
Originally, clone pat.pk0035.g9.f was structurally annotated as
Ribonuclease homolog precursor (RSFR; Gga.46257) and func-
tionally annotated in chicken GOA database build 17 with only 4
annotations were assigned, all based on IEA evidence. When this
gene is re-annotated using chicken GOA database build 46, 66
annotations were assigned, of which only 12 were IEA-based. The
total GO annotation confidence score for this particular gene is
226, representing 80% of the total GO annotation confidence
score (283) of all 9 genes functionally re-annotated to chicken
GOA database build 46. Re-annotation structurally annotates
clone pat.pk0035.g9.f as ‘‘Marker protein’’ (Ch21; Gga.739). This
gene is functionally annotated in chicken GOA database 46 to 22
annotations, all based on IEA evidence.
GOSlim sets are designed to summarize GO datasets and,
although this approach loses detailed functional information, it is
suitable for comparing and visualizing the overall effect of
functional re-annotation. The whole-microarray GOSlim model-
ing showed increases in GO annotation for all GOSlim groups for
each of the three GO ontologies. However, re-annotation results in
more unique GO annotations and increased GO depth, thus more
GO annotation detail. Summarizing these GO annotations to
relevant, more global GOSlim groups results in a higher GO
annotation count for global GO terms for GO Cellular
Component ontology terms such as ‘‘cellular_component’’ or
‘‘cell’’. Similarly for GO Molecular Function, this phenomenon is
shown for the GO group ‘‘binding’’, which is a global GO term
that accounts for 74.4% of the chicken gene products in the
Molecular Function ontology.
GOSlim modeling of the differentially expressed mRNA dataset
showed both increased and decreased GOSlim groups. In some
instances this reduction is a direct result of re-annotation. For
example, the number of GO annotations summarized to
‘transporter activity’ decreases, but in contrast the more specific
GO terms ‘protein transporter activity’ and ‘ion transmembrane
transporter activity’ have more GO annotations. As expected, re-
annotation results in increased GO annotation granularity or
specificity for the differentially expressed mRNA dataset.
Because the higher order GO terms used in the GOSlim
analysis do not describe in detail which canonical pathways and
networks are represented by the datasets, we used Ingenuity
Pathway Analysis (IPA) to retrieve all significant canonical
pathways. We clearly increased the canonical pathway coverage
and lowered statistical variance in assigning pathways.
In order to calculate the statistical variance using the Fisher’s
exact test, we used the Agilent 44K chicken microarray as
reference list, which is closest to the FHCRC 13k chicken cDNA
microarray. Although not optimal, this approach provides the best
evaluative means for assessing the impact of re-annotation on
functional genomics data. In addition, IPA uses the Fisher’s exact
test for significance calculations, which assumes gene-indepen-
dence. However, in biology, gene expression cannot always, or
arguably is never, independent [45]. Regardless, the method we
used does provide a standard system for comparing pre and post
re-annotation and there is a clear difference.
At the time of manuscript preparation, the most current publicly
available structural and functional annotations were used. We
improved the total structural annotations by 10.5 fold, the
functional annotations by about 6.3 fold and the pathway coverage
by 6.9 fold, since the last update of the FHCRC array in 2006.
The time period from the update until our data analysis covers 40
months, which represents 20 UniGene updates, 40 GOA chicken
database updates and 13 IPA database updates. This continual
updating suggests that re-annotation of our annotations would
again be necessary in about 4 to 6 months.
Even though it is clear that re-annotation has a significant effect
on data quality, the most important question for knowledge
generation is whether or not it has an impact on data interpretation.
The FHCRC 13K chicken cDNA microarray has been used for
cancer [21,22], growth and development [25], and host-pathogen
interaction [23,24] research. We re-annotated differentially ex-
pressed mRNAs identified in work using the FHCRC 13K chicken
cDNA microarray to study genetic differences in chicken responses
to a Salmonella enterica Serovar enteritidis infection [24]. This work
reported several candidate genes for genetic resistance to Salmonella
infection. The impact of our re-annotation on interpretation of this
study can be described on three levels.
First, the previous annotation allowed only for candidate gene
identification and, as stated by Zhou et al., in the paper, one
constraint at the time was lack of annotation allowing in-depth
analysis of signal transduction pathways. Our re-annotation increased
the pathway coverage of several major immune response pathways
(Table 6), which allows more comprehensive modeling of signalling
pathways. One example is the re-annotation of the FAS molecule.
Originally, Zhou et al. did not have any nucleotide accession
numbers assigned for the FAS gene, which hindered retrieval of
additional cross-reference gene information from public databases
and down-stream pathway modeling. Our re-annotation provides the
necessary cross-reference information and allows identification of
canonical pathways involving FAS (Table 5 and 6).
Second, the re-annotated data allows us to confirm and
consolidate suggestions from Zhou et al. For example, differential
expression of CD3epsilon, cytokine IL-1b, and chemokines ah294
(CCL5) were identified as key genes involved in the immune
response to SE. The re-annotated data not only allowed chicken-
specific functional annotation of these genes, but allowed
identification of their related pathways with greater confidence
and coverage (Table 5 and 6).
Third, re-annotation identified additional genes involved in
major immune pathways that were not identified in the original
work. For example, Zhou et al., identified differential regulation of
two ESTs (pat.pk0028.f8.f and pat.pk0032.e7.f), which both were
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structurally annotated to the T-cell surface glycoprotein CD28.
Re-annotation, however, showed that the EST pat.pk0028.f8.f
(GenBank AI980641) is more correctly structurally annotated to
protein tyrosine phosphatase type IVA member 1 (PTP4A1) and
EST pat.pk0032.e7.f (GenBank AI980751) is more correctly
structurally re-annotated to inducible T-cell co-stimulator (ICOS
or CD287). ICOS is interesting in that it shares structural and
functional similarities with CD28 and both are required for naı¨ve
CD4+ T-cell activation, yet ICOS contributes more to T cell
survival and proliferation during an immune response [46,47,48].
In addition, ICOS stimulates IL-10 expression, which in turn
influences B-cell immunity [47,49]. The EST that we structurally
re-annotated to ICOS, had increased expression in chickens
susceptible to SE infection with high SE burden. Increased ICOS
expression is linked to immune deregulation in several human
diseases including those of the gastrointestinal tract [47], in murine
colitis [50] and specifically, in Salmonella enterica serovar Typhimur-
ium infection in mice [51]. With the updated annotation, therefore,
we can now, demonstrate something that the previously published
work could not – that an ICOS-response mechanism has a role in
the genetic response to a natural Salmonella enterica serovar Enteritidis
(SE) infection using the chicken model.
Similarly, another EST with higher expression in chickens with
low SE burden (resistant birds) is pat.pk0024.f7.f, which was originally
structurally-annotated to P0498A12.26, a protein coding region from
the plant Oryza sativa. Not only is this NCBI record now obsolete, but
our re-annotation corrected the structural annotation to chicken
LOC693257 NK-lysin. NK-lysin is a known anti-microbial peptide,
expressed in T and NK cells [52], that inhibits LPS activity through
lipid A binding from several gram-negative bacteria, including
Salmonella species [53,54]. Infection of a porcine model with Salmonella
enterica serovar Typhimurium resulted in higher NK-lysin mRNA
expression [54]. Based on our re-annotation, we demonstrate that a
mechanism involving the genetic regulation of NK-lysin contributes
to a genetic resistance to SE in chicken.
In summary, although bio- and computational-technologies are
greatly accelerating functional genomics research, we propose that
re-annotation should be the standard first step when analysing
functional genomics data. This step is especially valuable for those
species in which data and resources are rapidly expanding,




We used the FHCRC Chicken 13K cDNA v.2.0 microarray
[19] and the significant differentially expressed mRNAs identified
by Zhou et al. [24] as our datasets. The microarray is accessible in
the National Center for Biotechnology Information Gene
Expression Omnibus (NCBI GEO; http://www.ncbi.nlm.nih.
gov/geo/, accession GPL 1836). The table of 15,769 rows was
downloaded and filtered for duplicate EST entries, which resulted
in 15,227 usable ESTs as described on the GEO website. We used
the EST clone IDs for further analysis. The identifiers of the
differentially expressed mRNAs were retrieved from the published
manuscript by Zhou et al. [24].
Structural and functional re-annotation
We re-annotated the entire microarray to the most recent
structural annotation using the ArrayIDer tool [32]. ArrayIDer
retrieves gene and protein information from both the NCBI
UniGene (http://www.ncbi.nlm.nih.gov/./unigene/) and Inter-
national Protein Index http://www.ebi.ac.uk/IPI/IPIhelp.html).
ESTs without structural annotations were searched against the
EBI InterPro database [55] using a modified version of
InterProScan to allow protein database searches with EST
nucleotide sequences translated to amino acid sequences [55].
Functional annotations for the re-annotated structural elements
were retrieved from AgBase [29], the Gene Ontology Annotation
(GOA) chicken database at EBI [56], and manual literature
curation. We used the GOA chicken database build 17, published
on January 22nd 2007, as a functional annotation baseline
available at the time the FHCRC 13K chicken cDNA v2.0
microarray was published. We used the GOA chicken database
build 46, published on July 30th 2009, as resource for re-
annotations. To compare the original and re-annotated data, we
used the 13K microarray and the differentially expressed mRNA
data, and both Gene Ontology (GO) and network-based modeling.
GO modeling
We used GOSlimViewer [29] from AgBase to group the GO
annotations to higher order terms based on the ‘GOA and whole
proteome GOSlim’ set for comparing the distribution of major
biological groups represented in each dataset. In addition, we used
the Gene Ontology Annotation Quality (GAQ) [33] score as a
quantitative measure to compare the quality of the assigned
functional annotations of the original and re-annotated structural
annotations. The GAQ score is a quantitative measure of the
functional annotation quality. The GAQ score correlates the
number of GO terms (‘breadth’), the GO DAG depth of the
annotations, and the type of evidence with which the GO
annotation is assigned. The evidence code ranking is designed to
give the highest score to GO annotation assigned by direct
experimental results. GO annotations assigned automatically
receive a lower evidence score in the GAQ score calculation
compared to annotations assigned with experimental evidence. In
addition to the standard GAQ calculations, we calculated the GO
evidence score separately excluding the GO annotations assigned
with evidence code ‘‘Inferred from Electronic Annotation’’ (IEA).
This allowed us to measure the re-annotation impact on GO
annotations assigned based on non-computational assessments.
Pathway and molecular network analysis
We used the Ingenuity Pathway Analysis application (IPA;
IngenuityH Systems, www.ingenuity.com) to identify and visualize
significant canonical pathways represented on the whole micro-
array and the differentially expressed mRNA datasets of the
experiment of Zhou et al. IPA uses publicly available databases
and ‘literature curated’ gene information to calculate statistically
significant canonical pathways. IPA uses a Fisher’s exact test to
calculate a P-value determining the probability of the gene
associations in the datasets and pathways. To calculate association
and gene significance, we used the Agilent 44K chicken
microarray (NCBI GEO accession: GPL4993) provided by IPA
as a reference list, since this reference is the closest chicken
microarray to the FHCRC microarray available in IPA. We used
p#0.05 to select pathways with significant gene representation.
We compared the original and re-annotated data based on the
represented significant canonical pathways and pathway coverage.
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